Clinical Trial Update: Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing whether alpha-linolenic acid supplementation affects hemostasis in nondiabetic, hypercholesterolemic adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: Yonsei University | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED